There is 1 paper on TIR70-180 in aging research: 1 trial in people.
1 paper studies it1 more mentions it1 finding
- Human trial1
Interventions
1Teneligliptin
upin humans1
1 study
Teneligliptin
upin humans1
Teneligliptin increases TIR70-180 in humans (elderly type 2 diabetes mellitus) (13.3% (95% CI, 6.0 to 20.6)).
Human trialelderly type 2 diabetes mellitus20 mg12 weeksn = 65
Latest
Diabetes & Metabolism Journal
Effects of Teneligliptin on HbA1c levels, Continuous Glucose Monitoring-Derived Time in Range and Glycemic Variability in Elderly Patients with T2DM (TEDDY Study)
Randomized trial in 65 peopleType 2 diabetes
ADA Scientific Sessions 2025 Abstract
Glucagon-Like Peptide 1 Receptor Agonist with Basal Insulin vs. Basal-Bolus Regimen on Glycemic Variability and Time-in-Range in Type 2 Diabetes Patients with Chronic Kidney Disease—A Randomised Controlled Trial
Randomized trial in 95 peopleChronic kidney disease